Shah Atman P, Nathan Sandeep
Section of Cardiology, Department of Medicine, The University of Chicago, Chicago, Illinois.
Section of Cardiology, Department of Medicine, The University of Chicago, Chicago, Illinois.
Am J Cardiol. 2018 Jul 15;122(2):356-363. doi: 10.1016/j.amjcard.2018.03.354. Epub 2018 Apr 17.
The diagnosis of acute coronary syndrome (ACS) encompasses ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation ACS (non-STEMI and unstable angina). In recent years, there have been improvements in the rates of death, cardiogenic shock, and recurrent myocardial infarction in patients with ACS, primarily due to the introduction of new pharmacological and interventional therapies, as well as the introduction of and adherence to new treatment guidelines. However, ACS still represents a considerable public health burden. Treatment recommendations for STEMI and non-ST-segment elevation differ and there is wide variation in practice patterns and adherence among and within hospitals especially for the latter diagnosis. Adoption of institutional protocols may help decrease variability and improve quality of care, efficiency, and, ultimately, patient outcomes. This report discusses the process of developing and implementing institutional protocols for patients with ACS, from initial medical contact to discharge and beyond.
急性冠状动脉综合征(ACS)的诊断包括ST段抬高型心肌梗死(STEMI)和非ST段抬高型ACS(非STEMI和不稳定型心绞痛)。近年来,ACS患者的死亡率、心源性休克发生率和心肌梗死复发率有所改善,这主要归功于新的药物和介入治疗方法的引入,以及新治疗指南的出台和遵循。然而,ACS仍然是一个相当大的公共卫生负担。STEMI和非ST段抬高型ACS的治疗建议不同,医院之间以及医院内部的实践模式和遵循情况存在很大差异,尤其是对于后者的诊断。采用机构协议可能有助于减少变异性,提高医疗质量、效率,并最终改善患者预后。本报告讨论了为ACS患者制定和实施机构协议的过程,从首次医疗接触到出院及出院后。